指南与共识泌尿生殖技术与安全PETCT

F-18 FDG PET/CT对手术治疗后肾细胞癌患者局部及远处疾病复发监测的诊断价值:能否辅助建立共识随访策略

Diagnostic value of F-18 FDG PET/CT for local and distant disease relapse surveillance in surgically treated RCC patients: Can it aid in establishing consensus follow up strategy?
指南 / 共识 · Nucl Med Rev Cent East Eur · 2018-01-01

回顾性纳入96例术后6-12个月内行FDG PET/CT随访的肾细胞癌患者,每位患者先行低剂量CT的FDG PET/CT,随即行全剂量增强CT。69例(71.9%)确认局部和/或远处复发。FDG PET/CT对局部复发的特异度为100%,增强CT为98.6%(P>0.05);增强CT对局部复发的敏感度为100%,FDG PET/CT为96%。

要点

  • FDG PET/CT对远处转移特异度99.6%、PPV 99.1%,增强CT分别为93.96%、87.5%。
  • 增强CT对远处转移敏感度93.3%、NPV 96.9%,高于FDG PET/CT。
  • 增强CT检出100%肺转移,FDG PET/CT仅检出80.6%(P<0.05)。

核心结论

  • FDG PET/CT似乎是肾细胞癌术后监测的高效工具,具有探查不常见远处复发部位的显著能力。

研究设计与样本

  • 回顾性研究,纳入96例术后6-12个月内转诊至核医学科行FDG PET/CT扫描的肾细胞癌患者;每位患者先行低剂量CT的FDG PET/CT,随即行全剂量增强CT;最终诊断基于后续随访的常规影像(CT/MRI)、FDG PET/CT或尽可能的病理组织学。

诊断标准与关键数值

  • 局部复发:FDG PET/CT特异度100%,增强CT特异度98.6%(P>0.05);增强CT敏感度100%,FDG PET/CT敏感度96%。
  • 远处转移总体:增强CT敏感度93.3%、NPV 96.9%、特异度93.96%、PPV 87.5%;FDG PET/CT特异度99.6%、PPV 99.1%。
  • 肺转移检出:增强CT检出100%,FDG PET/CT检出80.6%(P<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Aim of the study was to evaluate the diagnostic performance of FDG PET-CT for the detection of local and distant disease relapse in surgically treated patients with renal cell carcinoma (RCC).

MATERIAL AND METHODS: This retrospective study includes 96 patients underwent FDG PET-CT scanning in the post-surgical follow up within the first 6-12 months referred to nuclear medicine department, to perform PET/CT study. Each patient underwent FDG PET-CT with low dose CT, followed immediately by full dose Ce-CT. Sites of the relapse were categorized into local and distant recurrence. Distant recurrence sites were divided into lymph nodes, lung, bone, and other soft tissue sites. The final diagnosis of disease status was made on subsequent follow up by conventional imaging (CT/MRI), FDG PET-CT, or histopathology whenever possible.

RESULTS: Local and/or distant disease relapse was confirmed in 69 (71.9%) patients and the rest 28.1% were free. Regarding local recurrence FDG PET-CT showed specificity of 100% compared to 98.6% with Ce-CT (p > 0.05) and higher sensitivity noted with Ce-CT (100%) compared to 96% with FDG PET-CT. For global distant sites of metastases Ce-CT revealed high sensitivity and NPV of 93.3% & 96.9% respectively yet lower specificity (93.96%) and PPV (87.5%) was seen with Ce-CT compared to 99.6% and 99.1% with FDG PET-CT respectively. The higher Ce-CT sensitivity was attributed to its ability to detected 100% of cases of lung metastases compared to 80.6% with FDG PET-CT (P-value < 0.05).

CONCLUSION: FDG PET-CT appears to be a very efficient tool in post-surgical surveillance of patients with RCC with notable ability to probe even uncommon sites of distant recurrence.

来源:Nucl Med Rev Cent East Eur,查看原文。版权归原作者所有。

引用

  1. Elahmadawy MA, Elazab MSS, Ahmed S, et al. Diagnostic value of F-18 FDG PET/CT for local and distant disease relapse surveillance in surgically treated RCC patients: Can it aid in establishing consensus follow up strategy? Nucl Med Rev Cent East Eur. 2018. PMID: 30070347. doi:10.5603/NMR.2018.0024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。